Current Report Filing (8-k)
December 29 2017 - 4:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 29, 2017
Date of Report (Date of earliest event reported)
GALA
GLOBAL INC.
(Exact name of registrant as specified in
its charter)
NEVADA
|
000-52044
|
42-1771014
|
(State or other jurisdiction of
|
(Commission File
|
(IRS Employer Identification No.)
|
incorporation)
|
Number)
|
|
|
|
|
2780 South Jones Blvd., #3725, Las Vegas, Nevada
|
89146
|
(Address of principal executive offices)
|
(Zip Code)
|
(949) 851-9261
Registrant's telephone number, including area code
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 4.01 Changes
in Registrants Certifying Accountant.
On December 29, 2017 (the
“
Resignation
Date
”
) Pritchett, Siler and Hardy P.C. (“PSH”)
resigned as the independent registered public accounting firm for Gala Pharmaceutical, Inc. (formerly Gala Global Inc.) (the “Company”).
On December 29, 2017, the Company engaged Haynie & Company, Salt Lake City, Utah, as its new independent registered public
accounting firm. The change of the Company’s independent registered public accounting firm from PSH to Haynie & Company
was approved unanimously by our board of directors.
The reports of PSH on the Company’s financial
statements for the two most recent fiscal years did not contain an adverse or disclaimer of opinion and were not qualified or modified
as to uncertainty, audit scope, or accounting principles.
During the two most recent fiscal years and
through the Resignation Date, there were (i) no disagreements between the Company and PSH on any matter of accounting principles
or practices, financial statement disclosure, or auditing scope or procedures, which disagreement, if not resolved to the satisfaction
of PSH, would have caused PSH to make reference thereto in their reports on the consolidated financial statements for such years,
and (ii) no “reportable events” as that term is defined in Item 304(a)(1)(v) of Regulation S-K.
The Company provided PSH with a copy of this
Form 8-K and requested that PSH furnish it with a letter addressed to the Securities and Exchange Commission stating whether or
not PSH agrees with the above statements. A copy of such letter, dated December 29, 2017, is attached as Exhibit 16.1.
During the Company’s two most recent
fiscal years and in the subsequent interim period through the Resignation Date, the Company has not consulted with Haynie &
Company regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed,
or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written
report nor oral advice was provided to the Company that Haynie & Company concluded was an important factor considered by the
Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either
the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable
event (as described in Item 304(a)(1)(v) of Regulation S-K).
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Signatures
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
|
|
Date: December 29, 2017
|
By:
|
/s/ Maqsood Rehman
|
|
|
Maqsood Rehman
|
|
Title:
|
Chief Executive Officer
|